Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,400
Closed -$328K – 144
2024
Q3
$328K Hold
3,400
– – 0.21% 82
2024
Q2
$312K Hold
3,400
– – 0.2% 81
2024
Q1
$313K Hold
3,400
– – 0.22% 80
2023
Q4
$323K Hold
3,400
– – 0.27% 77
2023
Q3
$323K Hold
3,400
– – 0.27% 77
2023
Q2
$311K Hold
3,400
– – 0.27% 85
2023
Q1
$250K Buy
3,400
+900
+36% +$77.9K 0.26% 83
2022
Q4
$209K Buy
2,500
+450
+22% +$40.6K 0.3% 70
2022
Q3
$198K Hold
2,050
– – 0.34% 60
2022
Q2
$215K Hold
2,050
– – 0.33% 60
2022
Q1
$353K Buy
+2,050
New +$306K 0.4% 57

Other funds holding AMED

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s AMED Position: Q4 2024 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold out of Amedisys (AMED) in Q4 2024, closing a stake of 3,400 shares — an estimated $328K sold.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in AMED in Q1 2022 and held it in 11 quarters. The position peaked at $353K in Q1 2022. 292 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 3,400 Amedisys shares in Q4 2024, an estimated $328K.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Amedisys in Q1 2022 and held it in 11 quarters.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Amedisys position peaked at $353K in Q1 2022.
  • 292 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q4 2024, filed 5 Feb 2025.